203,29 €*

in Vorbereitung

Falls Sie eine Lieferung außerhalb DE, AT oder CH wünschen, nutzen Sie bitte unser Kontaktformular für eine Anfrage.

Although pancreatic cancer is one of the most serious forms of cancers, the outlook for patients could be improved. The lack of clinical symptoms of early, surgically removable disease most often limits curative treatment options. The aggressive tumor cell biology, leading to a locally advanced nature of the disease and to early metastases, allows curative resection in only 20% of patients at the time of diagnosis. This book gives insight into the current understanding of the management of pancreatic cancer and considers recent findings in cancer research. It provides answers to questions of how to know when cancer is respectable, how to proceed when the diagnosis comes too late for a curative approach, and how to assess different study results. Moreover, it highlights new upcoming therapeutic options and experimental approaches, which might further improve the future prospects for patients with pancreatic adenocarcinoma.



Pancreatic Cancer: Step by Step Forward
Pancreatic Cancer: Step by Step Forward
Diagnosis
CT and MR Imaging of Pancreatic Cancer
Nuclear Medical Methods for the Diagnosis of Pancreatic Cancer: Positron Emission Tomography
Therapy and Monitoring of Disease
Surgical Techniques for Resectable Pancreatic Cancer
Postoperative Staging of Pancreatic Cancer
Adjuvant Therapy in Patients with Pancreatic Cancer
First-Line Chemotherapy in Advanced Pancreatic Cancer
Second-Line Chemotherapy in Advanced Pancreatic Cancer
Neoadjuvant and Adjuvant Strategies for Chemoradiation
Primary Advanced Unresectable Pancreatic Cancer
Brachytherapy of Liver Metastases
Detection of Disease Recurrence and Monitoring of Therapy
Surgical Palliation of Advanced Pancreatic Cancer
New Treatment Strategies and Outlook
Antiangiogenic Strategies in Pancreatic Cancer
Targeted Therapy of the Epidermal Growth Factor Receptor in the Treatment of Pancreatic Cancer
Antisense Therapeutics for Tumor Treatment: The TGF-beta2 Inhibitor AP 12009 in Clinical Development Against Malignant Tumors
NF-? B as a Molecular Target in the Therapy of Pancreatic Carcinoma
Immunotherapeutic Approaches in Pancreatic Cancer
Src Kinase and Pancreatic Cancer.
ISBN 978-3-540-71266-4
Artikelnummer 9783540712664
Medientyp Buch
Copyrightjahr 2007
Verlag Springer, Berlin
Umfang XII, 186 Seiten
Abbildungen XII, 186 p. 48 illus., 12 illus. in color.
Sprache Englisch